Hot Products

Basic Information

Post buying leads

Suppliers

Cas Database

Name	TIQUIZIUM BROMIDE	EINECS	1312995-182-4
CAS No.	71731-58-3	Density	N/A
PSA	56.48000	LogP	2.36720
Solubility	N/A	Melting Point	278-281° (dec)
Formula	C19H24 N S2 . Br	Boiling Point	N/A
Molecular Weight	410.442	Flash Point	N/A
Transport Information	N/A	Appearance	N/A
Safety	Poison by subcutaneous, intravenous and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Br⁻, NO_x, and SO_x.	Risk Codes	N/A
Molecular Structure		Hazard Symbols	N/A
Synonyms	2H-Quinolizinium,3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide, (5R,9aR)-rel- (9CI);2H-Quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide,trans-; HS 902; HSR 902; Thiaton; Tiquizium bromide	Article Data	1

TIQUIZIUM BROMIDE Chemical Properties

IUPAC Name:(5R,9aR)-7-(dithiophen-2-ylmethylidene)-5-methyl-1,2,3,4,6,8,9,9a-
octahydroquinolizin-5-ium bromide(71731-58-3)
Synonyms: Tiquizium bromide ; (5R,9aR)-7-(dithiophen-2-ylmethylidene)-5-methyl-1,2,3,4,6,8,9,9a-octahydroquinolizin-5-ium bromide ; Tiquizium ; 2H-Quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide, (5R,9aR)-rel- (9CI) ; 2H-Quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-, bromide, trans- ; HS 902;HSR 902 ; Thiaton
CAS:71731-58-3
MF: C₁₉H₂₄BrNS₂
MW: 410.43
Mol File: 71731-58-3.mol
Melting point :246 ~ 248 ℃
Appearance: Tiquizium bromide (71731-58-3) is prism crystals.

TIQUIZIUM BROMIDE Uses

1.Tiquizium bromide (71731-58-3) is antispasmodic, which can be obtained from 2 - hydroxyethyl-pyridine of the raw material;
2.Tiquizium bromide (71731-58-3) have good effects on spasm, gastric secretion inhibition and anti-ulcer caused by anti-acetylcholine of parasympathetic nerve endings.

TIQUIZIUM BROMIDE Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	ld50	intraperitoneal	56700ug/kg (56.7mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
dog	ld50	intravenous	14200ug/kg (14.2mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
dog	ld50	oral	662mg/kg (662mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
dog	ld50	subcutaneous	129mg/kg (129mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	intraperitoneal	83700ug/kg (83.7mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	intravenous	10300ug/kg (10.3mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	oral	578mg/kg (578mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
mouse	ld50	subcutaneous	82100ug/kg (82.1mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	intraperitoneal	70500ug/kg (70.5mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	intravenous	11400ug/kg (11.4mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	oral	1177mg/kg (1177mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.
rat	ld50	subcutaneous	169mg/kg (169mg/kg)	sense organs and special senses: mydriasis (pupillary dilation): eye behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea	oyo yakuri. pharmacometrics. vol. 23, pg. 1, 1982.

TIQUIZIUM BROMIDE Safety Profile

Poison by subcutaneous, intravenous and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Br⁻, NO_x, and SO_x.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 71731-58-3